Your search returned 13 results.

Results
	1.	Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors: Priebat, Dennis A PMID: 28988646 Year: 2017 Citation: Lancet Oncology. 18(11):1493-1501, 2017 Nov Institution: Washington Cancer Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II DOI: https://dx.doi.org/10.1016/S1470-2045(17)30624-1 Add to cart (remove)
	2.	Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. MedStar authors: McCarron, Edward C PMID: 30509771 Year: 2019 Citation: Lancet Oncology. 20(1):88-99, 2019 01. Institution: MedStar Franklin Square Medical Center Medline publication type: Journal Article Form of publication: Journal Article All authors: Bandos H, Brufsky AM, Chia SK, Dakhil SR, Fehrenbacher L, Geyer CE Jr, Graham ML, Jeong JH, Lembersky BC, Mamounas EP, McCarron EC, Paik S, Rastogi P, Seay TE, Soori GS, Swain SM, Wade JL 3rd, Walshe JM, Wickerham DL, Wolmark N DOI: https://dx.doi.org/10.1016/S1470-2045(18)30621-1 Add to cart (remove)
	3.	Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. MedStar authors: Henshaw, Robert M PMID: 23867211 Citation: Lancet Oncology. 14(9):901-8, 2013 Aug. Institution: MedStar Washington Hospital Center Department: Orthopedic Oncology Medline publication type: Clinical Trial, Phase II Journal Article Multicenter Study Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Blay JY, Chawla S, Choy E, Ferrari S, Grimer R, Henshaw R, Jacobs I, Kroep J, Qian Y, Reichardt P, Rutkowski P, Schuetze S, Seeger L, Skubitz K, Staddon A, Thomas D DOI: http://dx.doi.org/10.1016/S1470-2045(13)70277-8 Add to cart (remove)
	4.	Comprehensive guidance on the diagnosis and management of primary mesenchymal tumours of the thyroid gland. [Review] MedStar authors: Burman, Kenneth D Wartofsky, Leonard PMID: 33152312 Year: 2020 Citation: Lancet Oncology. 21(11):e528-e537, 2020 11. Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Araque KA, Avadhanula S, Burman KD, Del Rivero J, Filie AC, Gubbi S, Kebebew E, Klubo-Gwiezdzinska J, Raffeld M, Thakur S, Wartofsky L, Welch J DOI: https://dx.doi.org/10.1016/S1470-2045(20)30332-6 Add to cart (remove)
	5.	Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial. MedStar authors: Swain, Sandra M PMID: 26272770 Year: 2015 Citation: Lancet Oncology. 16(9):1037-48, 2015 Sep. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Adams PT, Baez-Diaz L, Bear HD, Brufsky AM, Costantino JP, Fehrenbacher L, Gaur R, Geyer CE Jr, Gross HM, Liu Q, Mamounas EP, Margolese RG, Mehta RS, Paik S, Rastogi P, Robidoux A, Senecal FM, Swain SM, Tang G, Wolmark N, Young JA DOI: http://dx.doi.org/10.1016/S1470-2045(15)00041-8 Add to cart (remove)
	6.	Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. MedStar authors: Rao, Suman PMID: 29129441 Year: 2017 Citation: Lancet Oncology. 18(12):1600-1609, 2017 Dec Institution: MedStar Franklin Square Hospital Medline publication type: Journal Article Form of publication: Journal Article All authors: Brahmer JR, Csoszi T, Cuffe S, Deitz AC, Fulop A, Gottfried M, Hotta K, Hui R, Lubiniecki GM, O'Brien M, Peled N, Rangwala R, Rao S, Reck M, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Zhang J DOI: https://dx.doi.org/10.1016/S1470-2045(17)30690-3 Add to cart (remove)
	7.	Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?. MedStar authors: Sugarbaker, Paul H PMID: 22846841 Year: 2012 Citation: Lancet Oncology. 13(8):e362-9, 2012 Aug. Institution: MedStar Washington Hospital Center Department: Surgery/General Surgery Medline publication type: Journal Article Form of publication: Journal Article All authors: Ryan DP, Sugarbaker PH DOI: http://dx.doi.org/10.1016/S1470-2045(12)70210-3 Add to cart (remove)
	8.	Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. MedStar authors: Swain, Sandra M PMID: 24095300 Year: 2013 Citation: Lancet Oncology. 14(12):1183-92, 2013 Nov. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Atkins JN, Azar CA, Baez-Diaz L, Bandos H, Bear HD, Brufsky AM, Costantino JP, Farrar WB, Fehrenbacher L, Geyer CE Jr, Mamounas EP, Margolese RG, Paik S, Rastogi P, Robidoux A, Sarwar S, Shibata HR, Swain SM, Tang G, Wolmark N DOI: http://dx.doi.org/10.1016/S1470-2045(13)70411-X Add to cart (remove)
	9.	Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study. MedStar authors: Henshaw, Robert M PMID: 31704134 Year: 2019 Citation: Lancet Oncology. 20(12):1719-1729, 2019 12. Institution: MedStar Washington Hospital Center Department: Orthopedic Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Blay JY, Chawla S, Choy E, Dai T, Gelderblom H, Grimer RJ, Henshaw R, Jandial D, Le Cesne A, Palmerini E, Reichardt P, Rutkowski P, Schuetze SM, Seeger L, Skubitz K DOI: https://dx.doi.org/10.1016/S1470-2045(19)30663-1 Add to cart (remove)
	10.	Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study. MedStar authors: Swain, Sandra M PMID: 32171426 Year: 2020 Citation: Lancet Oncology. 21(4):519-530, 2020 Apr. Institution: MedStar Health Department: Associate Dean for Research Development Medline publication type: Journal Article Form of publication: Journal Article All authors: Benyunes MC, Ciruelos E, Clark E, CLEOPATRA study group, Cortes J, Im SA, Im YH, Kim SB, Knott A, Loi S, Miles D, Monturus E, Restuccia E, Schneeweiss A, Semiglazov V, Swain SM DOI: https://dx.doi.org/10.1016/S1470-2045(19)30863-0 Add to cart (remove)
	11.	Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. MedStar authors: Kumar, Anjali S PMID: 26187751 Citation: Lancet Oncology. 16(8):957-66, 2015 Aug. Institution: MedStar Washington Hospital Center Department: Surgery/Colorectal Surgery Medline publication type: Clinical Trial, Phase II Journal Article Multicenter Study Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Avila K, Cataldo PA, Chow OS, Coutsoftides T, Dietz DW, Fichera A, Garcia-Aguilar J, Herzig DO, Hunt SR, Kumar AS, Marcet JE, Oommen S, Patil S, Polite BN, Smith DD, Stamos MJ, Ternent CA, Timing of Rectal Cancer Response to Chemoradiation Consortium, Varma MG DOI: http://dx.doi.org/10.1016/S1470-2045(15)00004-2 Add to cart (remove)
	12.	Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study. MedStar authors: Swain, Sandra M PMID: 23602601 Year: 2013 Citation: Lancet Oncology. 14(6):461-71, 2013 May. Institution: Washington Cancer Institute Medline publication type: Clinical Trial, Phase III Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Baselga J, Benyunes MC, Campone M, Ciruelos E, Clark E, Cortes J, Ferrero JM, Kim SB, Knott A, Ro J, Ross G, Schneeweiss A, Semiglazov V, Swain SM DOI: http://dx.doi.org/10.1016/S1470-2045(13)70130-X Add to cart (remove)
	13.	Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. MedStar authors: Swain, Sandra M PMID: 22704583 Year: 2012 Citation: Lancet Oncology. 13(7):734-42, 2012 Jul. Institution: Washington Cancer Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Anderson SJ, Baez-Diaz L, Brufsky AM, Costantino JP, Dakhil S, Falkson CI, Fehrenbacher L, Geyer CE Jr, Gralow JR, King KM, Lad T, Lembersky BC, Mamounas EP, Paterson AH, Perez EA, Robidoux A, Swain SM, Weir LM, Wolmark N, Zheng P DOI: http://dx.doi.org/10.1016/S1470-2045(12)70226-7 Add to cart (remove)

Powered by Koha